(Q39503895)

12 September 2017

title

Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression (English)

1 reference

evasion of host immune response

12 September 2017

0 references

1 reference

1 reference

1 reference

2

1 reference

12 September 2017

8

Michael Weller

1 reference

12 September 2017

1

Michel Mittelbronn

1 reference

12 September 2017

9

Jörg Wischhusen

1 reference

12 September 2017

Pia Zeiner

3

1 reference

12 September 2017

Yvonne Dombrowski

4

1 reference

12 September 2017

Brigitte Frank

5

1 reference

12 September 2017

Cornelia Zachskorn

6

1 reference

12 September 2017

Patrick N Harter

7

1 reference

12 September 2017

publication date

21 July 2011

1 reference

12 September 2017

published in

Acta Neuropathologica

1 reference

12 September 2017

volume

122

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

353-365

1 reference

ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor: a regulator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Cellular characterization of the peritumoral edema zone in malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

A proinflammatory cytokine inhibits p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

MIF signal transduction initiated by binding to CD74

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Mechanisms and effectors of MIF-dependent promotion of tumourigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Immunohistochemical localization of macrophage migration inhibitory factor (MIF) in tanycytes, subcommissural organ and choroid plexus in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0858-3

10.1007/S00401-011-0858-3

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference